Intranasal corticosteroid potency

Direct intravenous injection:
Use only methylprednisolone sodium succinate.
Reconstitute with provided diluent or add 2 ml of bacteriostatic water (with benzyl alcohol) for injection.
May be administered undiluted.
Administer directly into a vein over 3—15 minutes. Doses >= 2 mg/kg or 250 mg should be given by intermittent infusion (see below), unless the potential benefits of direct IV injection outweigh the potential risks (., life-threatening shock).
 
Intermittent intravenous infusion:
Use only methylprednisolone sodium succinate.
Dilute in D5W, % Sodium Chloride (NS), or D5NS injection. Haze may form upon dilution.
Infuse over 15—60 minutes. Large doses (., >= 500 mg) should be administered over at least 30—60 minutes.

Persons who are using drugs that suppress the immune system (., corticosteroids) are more susceptible to infections than healthy individuals. Chickenpox and measles , for example, can have a more serious or even fatal course in susceptible children or adults using corticosteroids. In children or adults who have not had these diseases or been properly immunized, particular care should be taken to avoid exposure. How the dose, route, and duration of corticosteroid administration affect the risk of developing a disseminated infection is not known. The contribution of the underlying disease and/or prior corticosteroid treatment to the risk is also not known. If a patient is exposed to chickenpox, prophylaxis with varicella zoster immune globulin (VZIG) may be indicated. If a patient is exposed to measles, prophylaxis with pooled intramuscular immunoglobulin ( IG ) may be indicated (see the respective package inserts for complete VZIG and IG prescribing information). If chickenpox or measles develops, treatment with antiviral agents may be considered.

In patients who may be susceptible to the intracranial effects of CO 2 retention (eg, those with evidence of increased intracranial pressure or brain tumors), MORPHABOND ER may reduce respiratory drive, and the resultant CO 2 retention can further increase intracranial pressure. Monitor such patients for signs of sedation and respiratory depression, particularly when initiating therapy with MORPHABOND ER. Opioids may also obscure the clinical course in a patient with a head injury. Avoid the use of MORPHABOND ER in patients with impaired consciousness or coma.



When to worry:
Anaphylaxis is an emergency and must be seen immediately by a vet. Often the reaction occurs in the vet clinic (sometimes within seconds of vaccination) or soon after the animal has left the clinic, although it can take up to 24 hours to manifest (so you should keep a close eye on the animal at home). The vet will usually rush the dog straight out to a treatment room, where it will receive oxygen, IV fluids, anti-histamines, adrenaline, anti-inflammatories and sometimes other drugs to aid in the treating of low blood pressure.



Intranasal corticosteroid potency

intranasal corticosteroid potency



When to worry:
Anaphylaxis is an emergency and must be seen immediately by a vet. Often the reaction occurs in the vet clinic (sometimes within seconds of vaccination) or soon after the animal has left the clinic, although it can take up to 24 hours to manifest (so you should keep a close eye on the animal at home). The vet will usually rush the dog straight out to a treatment room, where it will receive oxygen, IV fluids, anti-histamines, adrenaline, anti-inflammatories and sometimes other drugs to aid in the treating of low blood pressure.



Media:

intranasal corticosteroid potencyintranasal corticosteroid potencyintranasal corticosteroid potencyintranasal corticosteroid potencyintranasal corticosteroid potency

http://buy-steroids.org